Published in

American Society for Microbiology, Journal of Virology, 22(96), 2022

DOI: 10.1128/jvi.01502-22

Links

Tools

Export citation

Search in Google Scholar

Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model

Journal article published in 2022 by Laura M. Stephens, Kathleen A. Ross, Jason S. McLellan ORCID, Balaji Narasimhan, Steven M. Varga ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Respiratory syncytial virus (RSV) infection causes thousands of infections and deaths in children and elderly adults each year. Research in this field is of great importance as there remains no licensed vaccine to prevent RSV infections.